Anatolian Current Medical Journal
Alopecia areata after hepatitis C virus infection treatment: a case report
Yazarlar: Esma EROĞLU
Cilt 3 , Sayı 2 , 2021 , Sayfalar 185 - 187
Konular:Sağlık Bilimleri ve Hizmetleri
DOI:10.38053/acmj.886644
Anahtar Kelimeler:Alopecia areata,Hepatitis C virüs,Sofosbuvir / ribavirin
Özet: Interferon-free direct-acting antiviral (DAA) therapies in the chronic hepatitis C virus (HCV) infections have low side effects. Sofosbuvir / ribavirin (SOF / RBV) therapy combination is among in the currently approved treatment regimens. Aleopecia areata is a very rarely comlication of this treatment. A case of alopecia areata developed after SOF / RBV combination therapy in a patient with chronic hepatitis C infection is presented.
ATIFLAR
Atıf Yapan Eserler
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2021, title={Alopecia areata after hepatitis C virus infection treatment: a case report}, volume={3}, number={185–187}, publisher={Anatolian Current Medical Journal}, author={Esma EROĞLU}, year={2021} }
APA
KOPYALA
Esma EROĞLU. (2021). Alopecia areata after hepatitis C virus infection treatment: a case report (Vol. 3). Vol. 3. Anatolian Current Medical Journal.
MLA
KOPYALA
Esma EROĞLU. Alopecia Areata after Hepatitis C Virus Infection Treatment: A Case Report. no. 185–187, Anatolian Current Medical Journal, 2021.